Does PRP Work for Back and Neck Pain? What the Research Shows

A 2026 systematic review of 13 randomized controlled trials found that PRP can match or outlast steroid injections for sciatica and lumbar facet joint pain — while injections into the disc itself, and most stem cell products, showed limited or mixed results.

Sorting Hype From Evidence in Spine Care

Regenerative treatments for back and neck pain are heavily marketed, and the claims often run well ahead of the science. A 2026 systematic review published in the European Spine Journal helps cut through the noise. It pooled 13 randomized controlled trials — the highest tier of clinical evidence — to ask a focused question: for degenerative spine pain, which biologic injections actually work, and for which conditions?

The answer is genuinely useful precisely because it is not “everything works.” The benefit depends heavily on the specific diagnosis, the target being injected, and the type of biologic used.

What the Review Examined

The researchers grouped the treatments into three broad categories and compared them against standard options such as corticosteroid (cortisone) injections, saline, or sham procedures:

• PRP (platelet-rich plasma): a concentrated portion of your own blood, injected near an irritated nerve root, into a facet joint, or into a disc.
• BMAC (bone marrow aspirate concentrate): cells drawn from your own bone marrow.
• Stem and precursor cell products (MSC/MPC): donor-derived or culture-expanded cell preparations.

Outcomes were tracked with validated pain and disability scores (such as VAS/NRS for pain and ODI for function), and judged against the minimal clinically important difference — the threshold at which a change is large enough for a patient to actually notice.

Where PRP Performed Well

Sciatica From a Herniated Disc (Lumbar Radiculopathy)

Four randomized trials compared PRP to epidural steroid injections for sciatica caused by a herniated lumbar disc. A consistent pattern emerged: steroids worked faster in the first few weeks, but PRP produced greater relief by 3 to 6 months. In several trials, roughly 70% of PRP patients reached a clinically meaningful improvement at 6 months, compared with about half of those who received steroids. No serious adverse events were reported.

Lumbar Facet Joint Pain

For arthritis-related pain coming from the small facet joints of the lower back, a multicenter trial found that PRP led to better functional outcomes than corticosteroids at 6 months, with a higher proportion of patients qualifying as treatment responders. The advantage showed up most clearly in disability and responder measures rather than raw average pain scores.

Where the Evidence Was Weaker or Mixed

Neck (Cervical) Facet Pain

The single randomized trial of PRP for cervical facet pain found no meaningful difference between PRP and steroid injections at 3 to 6 months — both produced only small improvements. So the lumbar facet results should not be assumed to carry over to the neck.

Injections Into the Disc Itself (Intradiscal Therapy)

Here the picture was clearly less favorable. The largest trial of intradiscal PRP found no benefit over a saline injection, and one case of disc infection (spondylodiscitis) was reported. The likely reason is biological: the inside of a disc is a low-oxygen, acidic, nutrient-poor environment that may limit how well platelets and cells can work.

Bone Marrow and Stem Cell Products

This is an important counterweight to aggressive marketing. Bone marrow concentrate (BMAC) for discogenic back pain was found to be essentially equivalent to a sham injection. Autologous stem cell therapy likewise failed to outperform placebo on pain and function, though some imaging measures improved. Only one type — standardized, donor-derived precursor cells — showed promising longer-term signals, and those products remain investigational and are not widely available.

Why This Matters for Patients

The takeaway is not that regenerative medicine is a cure-all, nor that it is useless. It is that the right treatment depends on the right diagnosis. The evidence is strongest for targeted PRP in sciatica from a herniated disc and in lumbar facet joint arthritis, where it can offer relief that is at least as good as steroids and often longer-lasting. The evidence is weak or absent for injecting PRP into the disc itself, and for the bone marrow and stem cell products that are frequently oversold.

A few caveats are worth keeping in mind. Most of these trials were modest in size, used different PRP preparation methods, and followed patients for a year or less, so long-term durability is still being studied. Results in any individual case depend on an accurate diagnosis and a treatment matched to it — which is exactly why a careful evaluation comes first.

A Note From Clinical Experience

It is worth adding a real-world perspective to the data. Averaged results across many trials can understate what happens for the right patient. In practice, when PRP is matched to the correct diagnosis — a well-chosen case of sciatica or lumbar facet pain, with the injection placed precisely under ultrasound guidance — it can work extremely well, sometimes producing relief that is both substantial and durable. Dr. Borys has seen patients respond far better than a simple average would suggest.

That is the whole point of careful patient selection. The studies show PRP is a reasonable option for specific conditions; thoughtful diagnosis and technique are what turn “reasonable on average” into a genuinely good result for an individual.

Conclusion

For back and neck pain, this high-quality review supports a measured, evidence-informed approach: PRP is a reasonable non-surgical option for specific conditions like sciatica and lumbar facet pain, while claims about disc injections and stem cell cures should be viewed with healthy skepticism. The best next step is a thorough evaluation to confirm what is actually driving your pain and whether PRP is a sensible fit.